🔎 Trials Near Me

Dachaigh › Ailsean fala › North Carolina › Durham

Sgrùdaidhean clionaigeach Ailsean fala ann an Durham, NC

Tha 16 sgrùdaidhean airson Ailsean fala a’ lorg phàirtichean aig làraichean ann agus timcheall air Durham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

A’ fastadhSgrùdadh amharc
  • Duke University Medical Center, Durham
Gach aois · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT04242095

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

A’ fastadhÌre 3
  • Duke Cancer Center ( Site 0028), Durham
  • University of North Carolina at Chapel Hill ( Site 0040), Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT03486873

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Durham VA Medical Center, Durham
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

A’ fastadhÌre 3
  • Quetzal Site 27, Chapel Hill · 10 mìle air falbh
Aoisean 18 gu 71 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07504458

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

A’ fastadhÌre 1/2
  • UNC School of Medicine, Division of Hematology, Chapel Hill · 10 mìle air falbh
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT04588922

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

A’ fastadhÌre 3
  • Duke University Medical Center, Durham
  • University of North Carolina, Chapel Hill, Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT07007312

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

A’ fastadh
  • Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mìle air falbh
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT06296368

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

A’ fastadhÌre 2
  • Lineberger Cancer, Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT06665100

Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment

A’ fastadh
  • 2400 Pratt Street, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT06532773

Implementation of an Oral Chemotherapy Adherence Intervention

A’ fastadh
  • UNC Chapel Hill, Chapel Hill · 10 mìle air falbh
Aoisean 21 agus nas sine · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT06989489

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

A’ fastadhSgrùdadh amharc
  • Duke University Medical Center, Durham
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mìle air falbh
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

A’ fastadhÌre 1
  • University of North Carolina, Chapel Hill · 10 mìle air falbh
Aoisean 13 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT04771572

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

A’ fastadhÌre 1/2
  • Duke University Medical Center, Duke Cancer Center, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT03328078

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

A’ fastadhÌre 1
  • Duke Blood Cancer Center, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Màrt 2026 · NCT05735184

HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT

A’ fastadhÌre 1 tràth
  • Duke University Health System, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Faoi 2026 · NCT06731504

Sgrùdaidhean Ailsean fala ann am bailtean eile

Sgrùdaidhean eile ann an Durham

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.